Investigating the Mechanisms of Mindfulness-based Cognitive Therapy (MBCT)
NCT ID: NCT02226042
Last Updated: 2018-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2014-10-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants in remission from depression will be seen pre- and post-MBCT to assess the underlying neuropsychological mechanisms. All will be followed-up over 12 months to assess the relationship of these neuropsychological changes with relapse risk.
The research will focus primarily on changes in self-compassion, rumination, attention and structural brain changes, with secondary focus on other mechanisms of emotional processing and memory.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cortical Excitability in Obsessive-Compulsive and Related Disorders
NCT00029068
Development of the Neuroimaging Biomarker-based Prediction Model of Anxiety-related Disorders: Effect of Mindfulness-based Cognitive Therapy Using Neuroscience on the Brain
NCT05911412
Mindfulness Based Emotion Regulation Therapy in the Treatment of Depressive Rumination
NCT04560192
Brain, Emotions, and Mind-Wandering
NCT05345392
Translational Research Evaluating Neurocognitive Memory Processes
NCT01834677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The first group will take 36 participants in remission from major depression (rMDD) through the 8 week MBCT program.
* A control group of 36 rMDD participants will not receive the intervention.
* A group of never depressed healthy control participants will also be recruited.
Research visits for participants not undergoing MBCT will be separated by an 8 week gap.
All participants will be seen before and after the 8 weeks for completion of neuropsychological assessments and questionnaires.
rMDD participants will be followed up over the following 12 months to identify any predictors of relapse.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mindfulness-based Cognitive Therapy
Individuals currently in remission from depression will choose to enter the Mindfulness-based Cognitive Therapy (MBCT) arm and undergo the 8 week MBCT group programme
Mindfulness-based Cognitive Therapy
MBCT: Mindfulness-based Cognitive Therapy is an 8 week group-based programme consisting of approximately 12 participants per group. There is also a full one day of practice around week 6. MBCT was initially designed for individuals in remission from depression and at risk of relapsing. The intervention is a mix of mindfulness meditation, cognitive behavioural therapy exercises and psychoeducation. MBCT has been shown to be effective in reducing relapse risk over 12 months.
Non-MBCT arm
Individuals currently in remission from depression will choose not to undergo the 8 week MBCT group programme
No interventions assigned to this group
Healthy volunteers
Individuals who have never experienced major depression
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindfulness-based Cognitive Therapy
MBCT: Mindfulness-based Cognitive Therapy is an 8 week group-based programme consisting of approximately 12 participants per group. There is also a full one day of practice around week 6. MBCT was initially designed for individuals in remission from depression and at risk of relapsing. The intervention is a mix of mindfulness meditation, cognitive behavioural therapy exercises and psychoeducation. MBCT has been shown to be effective in reducing relapse risk over 12 months.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least two previous episodes of DSM-IV major depression in adulthood, diagnosed using the Mini International Neuropsychiatric Interview (M.I.N.I).
* Full or partial remission for at least three months with two depressive episodes within the last five years.
* A score of less than or equal to 12 on the Montgomery Asberg Depression Rating Scale (MADRS) mood assessment.
* If on medication, no recent or planned major changes
Healthy volunteers:
* In good psychological health screened with the M.I.N.I
All participants:
* in good physical health (to reduce risk of confounding physical health problems).
* sufficiently fluent in English to ensure valid understanding and completion of the tasks.
* minimum I.Q level of 80 to ensure sufficient understanding of the neurocognitive tasks administered.
* colour vision and acuity within normal/corrected to normal limits.
Exclusion Criteria
* Physical health or neurological disorders that might interfere with the interpretation of the tasks, including a history of significant head injury.
* In addition healthy volunteers will be without a history mental health disorders (DSM-IV)
* Current or previous experience of mindfulness-based treatments or extensive cognitive behavioural treatment, or planned participation in psychological treatments during the key time for the study (between pre and post visits).
* Planned major alteration in drug treatment for depression between pre and post visits.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manchester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kate Williams
PhD Student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Manchester
Manchester, Greater Manchester, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Williams K, Hartley S, Anderson IM, Birtwell K, Dowson M, Elliott R, Taylor P. An ongoing process of reconnection: A qualitative exploration of mindfulness-based cognitive therapy for adults in remission from depression. Psychol Psychother. 2022 Mar;95(1):173-190. doi: 10.1111/papt.12357. Epub 2021 Jul 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MBCTMechanisms
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.